Healthcare Analytical Testing Services Market worth $12,470 million by 2031
The report "Healthcare Analytical Testing Services Market by Test Type (Cell-based, Bioanalytical, Raw Material, Microbial, Batch-Release, Genomic, Method Development & Validation, Endotoxin), End User (Pharma, Biopharma, Medical Device, Clinic) - Global forecast to 2031", The global healthcare analytical testing services market is expected to grow from USD 7,750 million in 2026 to USD 12,470 million by 2031, at a CAGR of 10.0% during the forecast period. The healthcare analytical testing services market is driven by increasing outsourcing, stringent regulatory requirements, rising clinical trials, and growing R&D expenditure. Demand is further supported by increasing development of biologics and biosimilars, which require specialized analytical testing throughout development and manufacturing.
Browse 350 market data Tables and 200 Figures spread through 350 Pages and in-depth TOC on "Healthcare Analytical Testing Services Market by Test Type (Cell-based, Bioanalytical, Raw Material, Microbial, Batch-Release, Genomic, Method Development & Validation, Endotoxin), End User (Pharma, Biopharma, Medical Device, Clinic) - Global forecast to 2031"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/healthcare-analytical-testing-services-market-108923833.html
By type, the bioanalytical testing services segment accounted for the largest market share in 2025.
Bioanalytical testing services dominated the market, supported by increasing demand for pharmacokinetic & toxicokinetic testing, immunogenicity testing, biomarker testing, and bioassays. Growing development of complex biologics and advanced therapies is further strengthening demand for these services.
By end user, the pharmaceutical companies segment accounted for the largest share of the healthcare analytical testing services market in 2025.
Pharmaceutical companies accounted for the largest market share in 2025, driven by increasing outsourcing of analytical testing and the need for method validation, stability, quality control, batch-release, and impurity testing. Biopharmaceutical companies are also expected to show strong demand as biologics development expands.
By region, the Asia Pacific is expected to register the highest growth rate during the forecast period.
Asia Pacific is expected to register the highest CAGR, supported by expanding pharmaceutical and biopharmaceutical R&D, increasing outsourcing, rising clinical trial activity, and investments in laboratory infrastructure. China, India, Japan, and South Korea are key contributors to regional growth.
As of 2025, the leading companies in the healthcare analytical testing services market include Eurofins Scientific SE (Luxembourg), LabCorp Holdings Inc. (US), WuXi AppTec (China), Charles River Laboratories (US), SGS SA (Switzerland), Thermo Fisher Scientific Inc. (US), Medpace Holdings, Inc. (US), Sartorius AG (Germany), Intertek Group Plc (UK), Merck KGaA (Germany), and SourceBio International Limited (UK).
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: [email protected]
Visit Our Website: https://www.marketsandmarkets.com
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Healthcare Analytical Testing Services Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
